- 全部删除
您的购物车当前为空
Solcitinib (GLPG-0778) 是一种可口服的,选择性的竞争性JAK1抑制剂,IC50值为 9.8 nM,可用于银屑病的研究。它对其选择性是对 JAK2、JAK3 和 TYK2 的 11、55 和 23 倍。


为众多的药物研发团队赋能,
让新药发现更简单!
Solcitinib (GLPG-0778) 是一种可口服的,选择性的竞争性JAK1抑制剂,IC50值为 9.8 nM,可用于银屑病的研究。它对其选择性是对 JAK2、JAK3 和 TYK2 的 11、55 和 23 倍。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 153 | In stock | |
| 5 mg | ¥ 328 | In stock | |
| 10 mg | ¥ 463 | In stock | |
| 25 mg | ¥ 788 | In stock | |
| 50 mg | ¥ 1,080 | In stock | |
| 100 mg | ¥ 1,550 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 348 | In stock |
Solcitinib 相关产品
| 产品描述 | Solcitinib (GLPG-0778) (GSK2586184, GLPG0778) is a JAK1 inhibitor. Solcitinib may be potentially used for the treatment of psoriasis, ulcerative colitis, and systemic lupus erythematosus. |
| 靶点活性 | JAK1:8-9 nM |
| 激酶实验 | In vitro HotSpotSM kinase profiling of 289 kinases is performed. The assay is conducted in the presence of 10 μM [33P]-ATP, using brigatinib concentrations ranging from 0.05 nM to 1 μM. |
| 别名 | 索西替尼, GSK-2586184, GLPG-0778 |
| 分子量 | 389.45 |
| 分子式 | C22H23N5O2 |
| CAS No. | 1206163-45-2 |
| Smiles | CC1(C)CN(C1)C(=O)c1ccc(cc1)-c1cccc2nc(NC(=O)C3CC3)nn12 |
| 密度 | 1.40 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 10 mg/mL (25.68 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容